Citadel Advisors
TGX

Citadel Advisors’s THERAGENICS CORP TGX Stock Holding History

Citadel Advisors’s Portfolio TGX Stock Details TGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-15,221
Closed -$33K – 7458
2013
Q3 		$33K Buy
+15,221
New +$32.5K ﹤0.01% 5998

Citadel Advisors's TGX Position: Q4 2013 in Review

Citadel Advisors sold out of THERAGENICS CORP (TGX) in Q4 2013, closing a stake of 15,221 shares — an estimated $33K sold.

Citadel Advisors first reported a position in TGX in Q3 2013 and held it in 1 quarter. The position peaked at $33K in Q3 2013. 0 funds tracked by Wall St. Rank hold TGX as of Q4 2013.

  • Citadel Advisors reported no remaining THERAGENICS CORP position as of Q4 2013 after selling out during the quarter.
  • Citadel Advisors sold 15,221 THERAGENICS CORP shares in Q4 2013, an estimated $33K.
  • Citadel Advisors first reported a position in THERAGENICS CORP in Q3 2013 and held it in 1 quarter.
  • Citadel Advisors's THERAGENICS CORP position peaked at $33K in Q3 2013.
  • 0 funds tracked by Wall St. Rank held THERAGENICS CORP as of Q4 2013.

Based on Citadel Advisors's 13F filing for Q4 2013, filed 14 Feb 2014.